FDG 联合 PiB PET 在记忆诊所诊断认知障碍患者中的价值

IF 4.8 1区 医学 Q1 NEUROSCIENCES
Fang Liu, Yudi Shi, Qiuyan Wu, Huifeng Chen, Ying Wang, Li Cai, Nan Zhang
{"title":"FDG 联合 PiB PET 在记忆诊所诊断认知障碍患者中的价值","authors":"Fang Liu,&nbsp;Yudi Shi,&nbsp;Qiuyan Wu,&nbsp;Huifeng Chen,&nbsp;Ying Wang,&nbsp;Li Cai,&nbsp;Nan Zhang","doi":"10.1111/cns.14418","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aims</h3>\n \n <p>To analyze the value of <sup>18</sup>F-fluorodeoxyglucose (FDG) positron emission tomography (PET) combined with amyloid PET in cognitive impairment diagnosis.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A total of 187 patients with dementia or mild cognitive impairment (MCI) who underwent <sup>11</sup>C-Pittsburgh compound B (PiB) and FDG PET scans in a memory clinic were included in the final analysis.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Amyloid-positive and amyloid-negative dementia patient groups showed a significant difference in the proportion of individuals presenting temporoparietal cortex (<i>p</i> &lt; 0.001) and posterior cingulate/precuneus cortex (<i>p</i> &lt; 0.001) hypometabolism. The sensitivity and specificity of this hypometabolic pattern for identifying amyloid pathology were 72.61% and 77.97%, respectively, in patients clinically diagnosed with AD and 60.87% and 76.19%, respectively, in patients with MCI. The initial diagnosis was changed in 32.17% of patients with dementia after considering both PiB and FDG results. There was a significant difference in both the proportion of patients showing the hypometabolic pattern and PiB positivity between dementia conversion patients and patients with a stable diagnosis of MCI (<i>p</i> &lt; 0.05).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Temporoparietal and posterior cingulate/precuneus cortex hypometabolism on FDG PET suggested amyloid pathology in patients with cognitive impairment and is helpful in diagnostic decision-making and predicting AD dementia conversion from MCI, particularly when combined with amyloid PET.</p>\n </section>\n </div>","PeriodicalId":154,"journal":{"name":"CNS Neuroscience & Therapeutics","volume":"30 2","pages":""},"PeriodicalIF":4.8000,"publicationDate":"2023-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cns.14418","citationCount":"0","resultStr":"{\"title\":\"The value of FDG combined with PiB PET in the diagnosis of patients with cognitive impairment in a memory clinic\",\"authors\":\"Fang Liu,&nbsp;Yudi Shi,&nbsp;Qiuyan Wu,&nbsp;Huifeng Chen,&nbsp;Ying Wang,&nbsp;Li Cai,&nbsp;Nan Zhang\",\"doi\":\"10.1111/cns.14418\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Aims</h3>\\n \\n <p>To analyze the value of <sup>18</sup>F-fluorodeoxyglucose (FDG) positron emission tomography (PET) combined with amyloid PET in cognitive impairment diagnosis.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>A total of 187 patients with dementia or mild cognitive impairment (MCI) who underwent <sup>11</sup>C-Pittsburgh compound B (PiB) and FDG PET scans in a memory clinic were included in the final analysis.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Amyloid-positive and amyloid-negative dementia patient groups showed a significant difference in the proportion of individuals presenting temporoparietal cortex (<i>p</i> &lt; 0.001) and posterior cingulate/precuneus cortex (<i>p</i> &lt; 0.001) hypometabolism. The sensitivity and specificity of this hypometabolic pattern for identifying amyloid pathology were 72.61% and 77.97%, respectively, in patients clinically diagnosed with AD and 60.87% and 76.19%, respectively, in patients with MCI. The initial diagnosis was changed in 32.17% of patients with dementia after considering both PiB and FDG results. There was a significant difference in both the proportion of patients showing the hypometabolic pattern and PiB positivity between dementia conversion patients and patients with a stable diagnosis of MCI (<i>p</i> &lt; 0.05).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Temporoparietal and posterior cingulate/precuneus cortex hypometabolism on FDG PET suggested amyloid pathology in patients with cognitive impairment and is helpful in diagnostic decision-making and predicting AD dementia conversion from MCI, particularly when combined with amyloid PET.</p>\\n </section>\\n </div>\",\"PeriodicalId\":154,\"journal\":{\"name\":\"CNS Neuroscience & Therapeutics\",\"volume\":\"30 2\",\"pages\":\"\"},\"PeriodicalIF\":4.8000,\"publicationDate\":\"2023-08-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cns.14418\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CNS Neuroscience & Therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/cns.14418\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS Neuroscience & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cns.14418","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

摘要

目的 分析18F-氟脱氧葡萄糖(FDG)正电子发射断层扫描(PET)联合淀粉样蛋白PET在认知障碍诊断中的价值。 方法 共有187名痴呆症或轻度认知障碍(MCI)患者在一家记忆诊所接受了11C-匹兹堡化合物B(PiB)和FDG正电子发射断层扫描,并纳入最终分析。 结果 淀粉样蛋白阳性和淀粉样蛋白阴性痴呆患者组在颞顶叶皮层(p <0.001)和扣带回后/楔前皮层(p <0.001)代谢减低的比例上存在显著差异。在临床诊断为AD的患者中,这种低代谢模式鉴定淀粉样病理的敏感性和特异性分别为72.61%和77.97%,在MCI患者中分别为60.87%和76.19%。32.17%的痴呆症患者在同时考虑了 PiB 和 FDG 结果后改变了最初的诊断。痴呆症转化患者和 MCI 诊断稳定患者中出现低代谢模式和 PiB 阳性的患者比例存在明显差异(p < 0.05)。 结论 FDG PET显示的颞顶叶和后扣带回/楔前皮层代谢减低提示认知障碍患者存在淀粉样病变,有助于诊断决策和预测从MCI转化而来的AD痴呆,尤其是与淀粉样蛋白PET结合使用时。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

The value of FDG combined with PiB PET in the diagnosis of patients with cognitive impairment in a memory clinic

The value of FDG combined with PiB PET in the diagnosis of patients with cognitive impairment in a memory clinic

Aims

To analyze the value of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) combined with amyloid PET in cognitive impairment diagnosis.

Methods

A total of 187 patients with dementia or mild cognitive impairment (MCI) who underwent 11C-Pittsburgh compound B (PiB) and FDG PET scans in a memory clinic were included in the final analysis.

Results

Amyloid-positive and amyloid-negative dementia patient groups showed a significant difference in the proportion of individuals presenting temporoparietal cortex (p < 0.001) and posterior cingulate/precuneus cortex (p < 0.001) hypometabolism. The sensitivity and specificity of this hypometabolic pattern for identifying amyloid pathology were 72.61% and 77.97%, respectively, in patients clinically diagnosed with AD and 60.87% and 76.19%, respectively, in patients with MCI. The initial diagnosis was changed in 32.17% of patients with dementia after considering both PiB and FDG results. There was a significant difference in both the proportion of patients showing the hypometabolic pattern and PiB positivity between dementia conversion patients and patients with a stable diagnosis of MCI (p < 0.05).

Conclusion

Temporoparietal and posterior cingulate/precuneus cortex hypometabolism on FDG PET suggested amyloid pathology in patients with cognitive impairment and is helpful in diagnostic decision-making and predicting AD dementia conversion from MCI, particularly when combined with amyloid PET.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CNS Neuroscience & Therapeutics
CNS Neuroscience & Therapeutics 医学-神经科学
CiteScore
7.30
自引率
12.70%
发文量
240
审稿时长
2 months
期刊介绍: CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug development and novel methodologies for drug evaluation. The journal focuses on neurological and psychiatric diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, epilepsy, and drug abuse.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信